معرفی
Mary P. Watson is a Professor in the Department of Chemistry and Biochemistry at the University of Delaware's College of Arts & Sciences. Her research group focuses on developing innovative transition metal-catalyzed reactions for organic synthesis, with particular emphasis on methods for constructing challenging C(sp3) bonds and stereocenters. She received her A.B. from Harvard University in 2000, Ph.D. from UC Irvine in 2006, and completed an NIH Postdoctoral Fellowship at Harvard from 2006-2009.
Professor Watson's research program centers on transforming traditionally inert functional groups into valuable synthetic building blocks. Her group has pioneered approaches to use alkyl alcohols and amines as cross-coupling electrophiles, enabling novel disconnections for complex molecule synthesis. Current research directions include: developing alkyl alcohol and amine derivatives as cross-coupling electrophiles; transforming amino groups into various substituents; and creating enantioselective reactions of cationic intermediates using chiral transition metal catalysts.
Analysis of her recent publications reveals a strong focus on nickel-catalyzed deaminative reactions, particularly using alkylpyridinium salts as versatile intermediates. Her work spans fundamental mechanistic investigations to practical synthetic applications, with increasing emphasis on stereoselective transformations and pharmaceutical relevance.
Scientific recognition includes:
- Multiple publications highlighted in Synform and Synfacts
- Work featured in Derek Lowe's influential 'In the Pipeline' blog
- ACS DOC Summer Undergraduate Research Fellowship for student Mitchell Daneker
- Top 20 Most Downloaded JACS Articles designation
- Featured in JACS Young Investigators Virtual Issue
Professor Watson has successfully mentored numerous PhD students to completion, with graduates moving to positions at institutions including Providence College, Vertex Pharmaceuticals, Adesis, and the Naval Research Labs. Her group maintains active collaborations with pharmaceutical companies like Pfizer and other academic research groups. The Watson Lab also operates specialized facilities for air-sensitive synthetic chemistry and mechanistic studies, supporting their innovative research in transition metal catalysis.
